会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Biodegradable mixtures of polyphoshazene and other polymers
    • 可聚降解的聚苯乙烯和其他聚合物的混合物
    • US6077916A
    • 2000-06-20
    • US90374
    • 1998-06-04
    • Cato LaurencinHarry AllcockSobrasua IbimArchel AmbrosioMichael Kwon
    • Cato LaurencinHarry AllcockSobrasua IbimArchel AmbrosioMichael Kwon
    • A61F2/02A61F2/28A61F2/30A61K9/20A61L27/26C08G79/02C08L85/02C08F283/00
    • C08L85/02A61L27/26C08G79/025A61F2/28A61F2002/2835A61F2002/30062A61F2002/30677A61F2210/0004A61K9/2031A61K9/204Y10S525/903Y10S525/937Y10S525/938
    • Biodegradable polymeric compositions are provided, wherein biodegradable polyphosphazenes are combined with at least one other polymer, either in the form of a blend, a semi-interpenetrating network (semi-IPN), or an interpenetrating network IPN. The side groups and composition of the polyphosphazenes are used to determine the properties of the compositions, for example, the rate and extent of degradation, and mechanical properties. These are useful in biomedical applications, including controlled drug delivery and tissue regeneration, and environmental applications. In the most preferred embodiment, as demonstrated by the examples, the polyphosphazenes contain hydrophobic side groups, such as p-methylphenoxy and other aromatic groups, and groups which impart hydrolytic instability, such as amino acid alkyl esters, and degrade by surface erosion. A preferred example is ethyl glycinato-substituted polyphosphazene (PPHOS) with p-methylphenoxy as co-substituent. These are blended with other polymers, such as PLGA, which have desirable mechanical properties but which degrade by bulk erosion, so that the blend degrades by surface erosion. For the biomedical applications, FDA approved polymers, such as polymers of lactic and glycolic acids and their copolymers, are preferred. Methods for making these compositions also are provided.
    • 提供了可生物降解的聚合物组合物,其中可生物降解的聚磷腈与至少一种其它聚合物(混合物,半互穿网络(半IPN)或互穿网络IPN)的形式组合。 聚磷腈的侧基和组成用于确定组合物的性质,例如降解的速率和程度以及机械性能。 这些可用于生物医学应用,包括受控药物递送和组织再生以及环境应用。 在最优选的实施方案中,如实施例所证明的,聚磷腈含有疏水侧基如对甲基苯氧基和其它芳族基团,以及赋予水解不稳定性的基团,例如氨基酸烷基酯,并通过表面侵蚀降解。 优选的实例是具有对甲基苯氧基作为共取代基的甘氨酰胺取代的聚磷腈(PPHOS)。 这些与其它聚合物(例如PLGA)共混,其具有期望的机械性能但通过体积腐蚀而降解,使得共混物由于表面侵蚀而降解。 对于生物医学应用,FDA批准的聚合物,如乳酸和乙醇酸的聚合物及其共聚物是优选的。 还提供了制备这些组合物的方法。